Best Jensen, Rebecca
Kjølhede, Maria
Just, Jesper
Clegg, Lee-Ann
Baek, Rikke
Kaadt, Erik
Elfving, Betina
Hess, David C.
Andersen, Grethe
Jørgensen, Malene Møller
Blauenfeldt, Rolf Ankerlund
Drasbek, Kim Ryun https://orcid.org/0000-0003-2701-2741
Funding for this research was provided by:
Novo Nordisk Fonden (NNF20OC00060998)
Novo Nordisk Fonden (NNF20OC00060998)
Danish Neurological Society
Harboefonden
Danish Society for Neuroscience
Article History
Received: 20 March 2025
Accepted: 29 December 2025
First Online: 12 January 2026
Declarations
:
: The study was approved by the Central Denmark Region Committees on Health Research Ethics (ID no. 1-10-72-184-19) and the Danish Medicines Agency (jr. no. 2019081802, EUDAMED CIV-ID nr. 19-08-029484) and was registered in the Region’s Internal List of research projects (ID no. 1-16-02-333-19). Clinicaltrial.gov identifier: NCT04266639 (registration date: 2020-03-12). The study was monitored by the Good Clinical Practice unit Aalborg/Aarhus, Denmark. All patients signed an informed consent form before enrolling in the study. The study adheres to the CONSORT guidelines.
: Not applicable.
: The authors declare no competing interests.